Jarrow Formulas, Fem Dophilus, 5 Billion CFU, 60 Veggie Capsules

Vegan Keep Refrigerated 2 Clinically Effective Strains Vaginal & Urinary Tract Maintains and Balances Vaginal Microbiome and Urinary Tract Health with GR-1® & RC-14® Strains 30+ Years of Clinical Research Non-GMO Gluten Free Probiotic Supplement Non-GMO Project Verified IPRO™ Clinically Effective Probiotic Strains Over 30 years of clinical research supports the effectiveness of the 2 patented probiotic bacterial strains in Fem-Dophilus®. These beneficial strains populate the vaginal tract with healthy bacteria to balance the vaginal microbiome and help maintain a healthy vaginal and urinary tract. These two strains are the most clinically published strains for vaginal health worldwide**, and were carefully selected due to their effectiveness in these studies. A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid, enhances probiotic bacterial survival to the lower intestine, and into the vaginal tract. Additionally, the package contains a smaller, Activ-Vial™ moisture-controlled desiccant bottle for better stability of probiotic bacteria. Strains Matter®: GR-1®/RC-14® and Vaginal Flora In one randomised clinical trial, 82% of women studied had healthy vaginal flora after 28 days of use at 1.6 billion CFU per day of a probiotic (formulated with L. rhamnosus, GR-1® and L. reuteri, RC-14®) compared to 50% before supplementation. Whereas in the control group (taking 10 billion CFU of common strain, L. rhamnosus GG) there was no improvement in the percentage of women with healthy vaginal flora. 1 1 Reid et al. (2001). FEMS Immunol. Med. Microbiol. **As of 1/8/2022